Genetic association analysis and frequency of NUDT15*3 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease in a large Dutch cohort
- 23 November 2024
- journal article
- research article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 24 (6) , 1-7
Abstract
Thiopurine drugs are cornerstone treatment for patients with inflammatory bowel disease (IBD). The most common adverse drug reaction is thiopurine-induced myelosuppression (TIM), that may partly be explained by the genetic polymorphism NUDT15*3. The aim of this retrospective study was to determine the NUDT15*3 polymorphism frequency and its association with TIM in an IBD patient population in the Netherlands. DNA from patients previously genotyped for TPMT was genotyped for NUDT15*3. In IBD patients treated with thiopurines association tests with TIM were conducted. Out of 988 included patients, 13 (1.3%) were heterozygous for NUDT15*3. Of all patients, 606 had IBD and received thiopurine treatment. In these patients, 8/606 (1.3%) were heterozygous polymorphic for NUDT15*3 of which 50.0% developed TIM compared to 2.3% in the wild type patients (p < 0.001). The study results show a clinically relevant prevalence of NUDT15*3 in the Dutch patient population. Its strong association with TIM suggests pre-therapeutic genotyping potentially clinically utile.Keywords
This publication has 32 references indexed in Scilit:
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel DiseasePLOS ONE, 2016
- NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicityNature Genetics, 2016
- NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel diseaseJournal of Gastroenterology, 2015
- NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBDThe Pharmacogenomics Journal, 2015
- Inherited NUDT15 Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2015
- A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopeniaNature Genetics, 2014
- Safety of Thiopurine Therapy in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Review article: thiopurines in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2006
- Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel diseasePharmacoepidemiology and Drug Safety, 2004